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The observed changes in the expression levels of the studied
genes indicate their potential role in tumor progression and a
possible impact on their expression of the mutant product of
the BRAF gene. Integrins and their ligands, OPN and TSP1, could
be considered potential markers in determining the prognosis
and treatment of PTC.
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Preoperative differential diagnosis of benign thyroid nodules
and thyroid cancer is an important issue of endocrinology. Preop-
erative identification of a tumor type allows a surgeon to deter-
mine an adequate surgical treatment and reduce complications.
The cytological analysis of samples obtained by the fine-needle
aspiration biopsy is limited in sensitivity and specificity and the
core biopsy is not safe to be used in patients with thyroid nodes
smaller than 2 cm. The most promising area in the preoperative
diagnosis of malignant tumors is molecular biomarkers, which
can be used to determine the surgical treatment and indications
for the target therapy. BRAF V600E is the most frequent genetic
alteration in thyroid cancer. It activates the MAP-kinase pathway
which causes changes in expression levels of extracellular matrix
proteins and some of their receptors. Changes in the expression
of integrin receptors and their ligands, such as osteopontin and
thrombospondin-1, contribute to tumor cell proliferation and
migration. The C-Jun pathway is also very important in pathogen-
esis of thyroid cancer. Changes in its activity can affect the
expression of GSTP enzyme which participates in hormone
metabolism. Altered MiRNA expression has been observed in a
variety of cancer states allowing their potential use as cancer
biomarkers.
The aim of this study was to evaluate integrins, angiogenic
factors, GSTP and MiRNAs as potential biomarkers for the diagno-
sis and prognosis of thyroid cancer.
112 samples of papillary thyroid cancer (PTC) and 120 samples
of benign nodular neoplasms were analyzed. The expression
levels of the studied genes were determined by RT-PCR. The
results were confirmed by immunohistochemical analysis. The
BRAF V600E mutation was determined by allele-specific real-
time PCR. The results showed that GSTP can be used for clinical
settings as a cancer-specific marker for thyroid neoplasms with
83–88% sensitivity, 70–80% specificity and 76–84% diagnostic
accuracy. Higher expression levels of integrins a2, a5, av, a9, b1,
b3 and IL-8, angiogenin, and VEGF were observed in malignant
tumors in comparison with the normal thyroid tissue (p < 0.05).
The BRAF V600E mutation was detected in 70% of all PTC cases.
In the BRAF V600E positive PTC samples the levels of ITGA3 and
ITGAV expression were higher than in the BRAF V600E negative
ones (p < 0.05). The expression of miRNA 21, 221, 222, 155 was
significantly increased in the cancer samples compared to the
benign neoplasms. Thus, the studied molecular markers could
be used for preoperative diagnosis of thyroid neoplasms and the
treatment approach.
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Background: Metabolic acidosis is a feature of many extreme
physiological and pathological conditions; it is characterized by
mitochondria dysfunction, increased membrane permeability
and changes in the conformation of the protein molecules in vio-
lation of their enzymatic properties. In acidosis, intracellular pH
shifts to the acidic side, which gives antitumor effect to the cyto-
static agent the tumor was resistant to. It is known that the per-
itumoral zone is a buffer between the tumor and healthy tissue,
so abnormalities in the tumor microenvironment changing con-
ditions in peritumoral area will likely affect the tumor status
and its response to antitumor therapy. The degree of tissue meta-
bolic acidosis in affected area can be increased by blocking the
activity of mitochondria and their contribution to the energy sup-
ply of the cells and using pharmacological agents that cause sep-
aration of processes of cellular respiration and oxidative
phosphorylation. Thus, the conditions of energy blockade can
be created in the perifocal area of the tumor. The aim was to
study the possibility of increasing the influence of antitumor
cytostatic by modeling damages of the energy forming processes
in the peritumoral area of the tumor through the creation of
metabolic acidosis.
Material and methods: Experimental work fragment was car-
ried out in 60 rats with sarcoma 45 (S45) transplanted under the
back skin. Cyclophosphamide (C) was administered intraperi-
toneally twice at a dose of 5 mg/kg. On the tumor peritumoral
area perimeter (in 4 points) 0.25 ml of a 1% solution of ATP or
1% solution of diphenhydramine (D) were administered. Clinical
studies were performed on 60 patients diagnosedwith breast can-
cer. These patients underwent two cycles of CMFA chemotherapy:
C 800 mg/m2, methotrexate 30 mg/m2, fluorouracil 2000 mg/m2,
doxorubicin 80 mg/m[b]; on a background of peritumoral injec-
tion of 0.5 ml of a 1% solution of ATP or 1% solution of D.
Results: Modelling of metabolic acidosis in peritumoral area
was shown to result in dissociation of respiration processes and
oxidative phosphorylation of cells (suppression of SDH activity
by ATP by 62% and D by 57.9% and an increase in activity of aGFDG
by ATP and D by 154.7%) the ratio of SDH and aGFDG less than 1.
Morphologic study of S45 showed the development of wide
connective border in the subcapsular zone with the inclusion of
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